News
AlveoGene debuts to develop inhaled gene therapy technology
Today saw the debut of a new UK-based biotech, called AlveoGene, …
19805 items found
Patients
From the Margins: Gilead book launch shines light on health inequalities
On Wednesday 13th September, pharmaphorum headed to London’s Wellcome …
News
UK trial will test digital tinnitus therapy from Oto
Just over a year after completing a seed financing round, digital …
R&D
GLP-1 weight loss drugs: An overview and update
GLP-1 agonists like Ozempic, Wegovy, and Mounjaro are dramatically …
News
Moderna looks to its post-COVID growth prospects
With sales of its COVID-19 vaccines on the wane, Moderna has …
News
Alnylam's Onpattro clears FDA vote for ATTR-cardiomyopathy
Despite a sceptical appraisal by FDA reviewers, Alnylam's Onpattro …
Sales & Marketing
Sponsored
Before you start the strategic planning cycle: 5 essential things to streamline your approach
It’s about that time of year when many global teams turn their …
Oncology
News
Vydura is first NICE-backed oral GPCR for acute migraine
Pfizer's Vydura has become the first drug in the oral GPCR receptor …
Sales & Marketing
Sponsored
12 Questions with Stefan Woxström
Stefan Woxström leads the Europe and Canada business at AstraZeneca …
News
Oral phenylephrine vote may see OTC products pulled in US
An FDA advisory committee has concluded that a commonly used …
News
EU clears review of Xtandi in earlier-stage prostate cancer
The EMA will kick off a review of Astellas and Pfizer's prostate …
News
XRHealth buys NeuroReality in health XR marriage
Two players in medical extended reality (XR) – XRHealth and NeuroReality – have come together in a quest to build the biggest company in the sector.
Digital
Sponsored
The AI effect in pharma commercial strategy: From data to re...
Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
Patients
Deep Dive: Patients & Partnerships 2024
IN THIS ISSUE: The 2024 US Presidential race is nearing its end, but what does that mean for pharma?
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
R&D
From neurosurgery to focused ultrasound: Not if, but when
Therapeutic or focused ultrasound began being applied to neurologic conditions less than a decade ago, but its potential in a wide spectrum of brain applications is high.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
EHS&S for Biopharma & Pharma Summit
Implementing Corporate & Regulatory-Guided EHS Practices to Achieve Zero Biosafety, Ergonomic & Chemical Incidents for Employee Safety Across Global Facilities
R&D
Partner Content
Proteomic Based Drug Discovery Summit 2025
Determine Optimum Application of Proteomics to Accelerate Screening of Novel Targets, Unravel the Mode of Action, & Identify Biomarkers to Progress Small Molecule Drug Discovery & T
